Keyphrases
Mammalian Target of Rapamycin (mTOR)
100%
Pompe Disease
100%
Target of Rapamycin Signalling
100%
Pathophysiology
14%
Intracellular Signaling
14%
Muscle Cells
14%
Lysosomal Storage Disease
14%
Growth Factors
14%
Therapeutic Intervention
14%
Knockdown
14%
Dysregulation
14%
Muscle Wasting
14%
Autophagic
14%
Catabolic Activity
14%
Serine-threonine Kinase
14%
Lysosome
14%
Lysosomal Disease
14%
Targeted Therapy
14%
Neuromuscular Disease
14%
Arginine
14%
Atrophy
14%
Extracellular Signaling
14%
Glycogen
14%
Metabolic Disease
14%
Muscle Mass
14%
Target of Rapamycin Pathway
14%
Biosynthetic Processes
14%
Pompe
14%
Medicine and Dentistry
Glycogen Storage Disease Type II
100%
Mechanistic Target of Rapamycin
100%
Pathophysiology
14%
Myocyte
14%
Arginine
14%
Muscle Atrophy
14%
Growth Factor
14%
Lysosome
14%
Water-Electrolyte Imbalance
14%
Targeted Therapy
14%
Neuromuscular Disease
14%
Lysosomal Storage Disease
14%
Protein Serine Threonine Kinase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Glycogen Storage Disease Type 2
100%
Mammalian Target of Rapamycin
100%
Pathophysiology
14%
Mouse
14%
Lysosome Storage Disease
14%
Growth Factor
14%
Arginine
14%
Protein Serine Threonine Kinase
14%
Neuromuscular Disease
14%
Metabolic Disorder
14%
Muscle Atrophy
14%
Biochemistry, Genetics and Molecular Biology
Mechanistic Target of Rapamycin
100%
Mouse
14%
Kinase
14%
Phosphotransferase
14%
Serine
14%
Growth Factor
14%
Threonine
14%
Arginine
14%
Lysosome
14%
Lysosomal Storage Disease
14%
Neuroscience
Mammalian Target of Rapamycin
100%
Growth Factor
14%
Arginine
14%
Lysosome
14%
Neuromuscular Disorder
14%
Muscle Atrophy
14%
Protein Serine Threonine Kinase
14%